The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?

Non-inferiority trial to assess safety and efficacy, including rates of disease rebound and incidence of Long COVID development of ratutrelvir, a ritonavir-free treatment, compared to PAXLOVID® Separa ...

From clandestine vaccine deals to familial ties with EU-funded ventures, Von der Leyen's leadership has not only eroded ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at ...

If you want to understand why Secretary of Health and Human Services Robert F. Kennedy Jr. has halted $500 million in funding ...

The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?

When ideology overtakes pragmatism in crafting public policies, it portends danger to society. The recent decision by the ...

COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

Showing that his loyalty to his own anti-vax mentality is greater than his loyalty to President Donald Trump, Robert F.